Does METHYLPREDNISOLONE Cause Psychomotor hyperactivity? 105 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Psychomotor hyperactivity have been filed in association with METHYLPREDNISOLONE (Medroloan II SUIK). This represents 0.2% of all adverse event reports for METHYLPREDNISOLONE.
105
Reports of Psychomotor hyperactivity with METHYLPREDNISOLONE
0.2%
of all METHYLPREDNISOLONE reports
0
Deaths
37
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From METHYLPREDNISOLONE?
Of the 105 reports, 37 (35.2%) required hospitalization, and 2 (1.9%) were considered life-threatening.
Is Psychomotor hyperactivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLPREDNISOLONE. However, 105 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLPREDNISOLONE Cause?
Off label use (10,364)
Drug ineffective (9,959)
Product use in unapproved indication (4,115)
Condition aggravated (3,784)
Headache (3,419)
Fatigue (3,250)
Pyrexia (3,226)
Pain (3,165)
Nausea (3,105)
Pneumonia (3,006)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
ARIPIPRAZOLE (389)
OLANZAPINE (366)
SERTRALINE (288)
MONTELUKAST (282)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
Which METHYLPREDNISOLONE Alternatives Have Lower Psychomotor hyperactivity Risk?
METHYLPREDNISOLONE vs METHYLPREDNISOLONE ACEPONATE
METHYLPREDNISOLONE vs METHYLPREDNISOLONE HEMISUCCINATE
METHYLPREDNISOLONE vs METILDIGOXIN
METHYLPREDNISOLONE vs METOCLOPRAMIDE
METHYLPREDNISOLONE vs METOLAZONE